Lupus research, hydroxychloroquine and cardiovascular heart healthNews

New Lupus Research Highlights Heart Health

September 23, 2026

New research is offering another important reason for people living with lupus to have informed conversations with their healthcare providers about taking prescribed medications consistently.

A recent study examined the relationship between hydroxychloroquine (HCQ)—one of the most widely used treatments for systemic lupus erythematosus (SLE)—and cardiovascular risk. Researchers studied 248 adults with lupus, looking at hydroxychloroquine blood levels and longer-term medication use.

The researchers found that patients with very low HCQ blood levels and low long-term medication intake had higher estimated cardiovascular risk than patients with greater exposure to the medication. The findings add to growing research examining the relationship between lupus treatment and long-term heart health.

Why Heart Health Matters in Lupus

Lupus is a complex autoimmune disease that can affect many parts of the body, including the cardiovascular system. Understanding and managing cardiovascular risk can therefore be an important part of long-term lupus care.

Hydroxychloroquine has long been a foundational treatment for many people living with lupus. The new research provides another reason for patients and healthcare providers to discuss medication adherence, appropriate monitoring and cardiovascular health as part of an individualized treatment plan.

Turning Research Into Better Patient Conversations

Medication decisions should always be made in consultation with a qualified healthcare professional. Patients should not begin, stop or change the dosage of hydroxychloroquine—or any medication—based solely on the results of a research study.

At The Reid Foundation for Lupus®, we believe access to credible, understandable information can help people affected by lupus become better informed and more engaged in their healthcare. As research continues to advance our understanding of this complex disease, we will continue sharing developments that matter to the lupus community.

Source: Arthritis Care & Research / Yale School of Medicine.

READ MORE
New lupus research on measuring long-term organ damageNews

New Research Aims to Improve How Long-Term Damage Is Measured in Lupus

August 27, 2026

New research is advancing efforts to improve how doctors measure long-term organ damage in people living with systemic lupus erythematosus (SLE).

Researchers are working to modernize the SLICC/ACR Damage Index, a long-standing tool used to assess permanent damage that can develop over time as a result of lupus, its complications or treatment.

As part of the effort, 146 health professionals and people with lupus from 35 countries participated in a consensus process that reviewed 226 potential measures. The group ultimately narrowed those measures to 39 candidates for a proposed updated damage index.

The revised approach is intended to better reflect today’s understanding of lupus and current standards of care. Researchers are also considering how different types and levels of damage should be weighted so that the index can more accurately capture the long-term impact of the disease.

The updated index is still being developed and tested. The next steps include refining the scoring system and evaluating the revised tool for validity, reliability and responsiveness before it can be considered for broader use.

For people living with lupus, more accurate ways to measure long-term damage could help researchers and healthcare providers better understand disease progression, compare outcomes and improve future care.

For additional information, read the full research summary from the Lupus Foundation of America.

READ MORE
Artificial intelligence and lupus care researchNews

Artificial Intelligence Shows Promise in the Future of Lupus Care

August 27, 2026

Artificial intelligence is rapidly changing many areas of healthcare, and new research suggests it may also have an important role in the future of lupus care.

A 2026 review published in the medical journal Lupus examined current applications of artificial intelligence in systemic lupus erythematosus (SLE). Researchers evaluated how AI and machine-learning technologies are being studied to assist with diagnosis, monitor disease activity, predict flares and organ-specific complications, and potentially help personalize treatment.

Because lupus can affect people differently and symptoms and disease activity can change over time, identifying patterns that may help physicians anticipate changes in a patient’s condition could be particularly valuable. The review found promising developments in areas including flare prediction, cardiovascular risk assessment and the analysis of kidney biopsies related to lupus nephritis.

However, researchers emphasized that significant work remains before these technologies can become part of routine lupus care. Many AI models still require broader validation, greater transparency and testing across more diverse patient populations. The review also reports that no AI tool evaluated for SLE has yet received regulatory clearance.

For people living with lupus, these advances offer an encouraging look at how technology may eventually support earlier detection of changes in disease activity and more individualized care. Continued research will be essential to ensure that these tools are accurate, clinically useful and equitable for the diverse communities affected by lupus.

For additional information, read the full research abstract and publication details on PubMed.

READ MORE
News

TRFL Chair Bryant Reid – Selected for Lifetime Achievement of the President’s Volunteer Service Award

June 5, 2024

In recognition of his outstanding volunteer contributions in community service to the United States, Bryant Reid was selected for Lifetime Achievement of the President’s Volunteer Service Award. This prestigious recognition is a testament to his steadfast commitment, dedication, and selflessness in serving others throughout his lifetime “His tireless efforts and countless hours of volunteer work, with a primary focus in the area of securing equitable treatment and cures for those with lupus, have undoubtedly made a profound impact on the lives of many individuals and communities. With the 2018 establishment of the Reid Foundation for Lupus, Inc, the impact of his commitment will only continue to expand in the future.

 

The 2024 awards will be presented in Dallas, Texas, at the annual gala for Anna’s House Domestic Violence Shelter, scheduled to be held on Saturday, October 5, 2024. As a 2024 awardee, Mr. Reid will receive a personalized certificate, as well as a congratulatory letter from the White House, signed by President Joe Biden.”

 

 

READ MORE

Bryant Reid Featured Speaker At The 100 Black Men of Atlanta Inc. Event

September 28, 2023

Bryant Reid, Founder and Board Chair, of The Reid Foundation for Lupus, Inc. (TRFL) was the featured speaker at the September 12, 2023, meeting of the General Body of the 100 Black Men of Atlanta Inc. Also, speaking at the event was Georgia Tech’s Men’s Head Basketball Coach Damon Stoudamire. The meeting was held in downtown Atlanta.

 

In his presentation, Mr. Reid spoke passionately about The Reid Foundation for Lupus, which he founded in 2018. He noted that lupus predominantly affects people of color. It, and those afflicted with this incurable disease, have not always received the support needed to provide relief to lupus victims. When Mr. Reid was diagnosed with the disease in 2009, he said he knew that he had to do something to help improve the quality of life for people living with lupus. The Reid Foundation for Lupus, Inc. was created out of this conviction.

 

The priorities of TRFL specifically include patient care programs, research, promotion of lupus awareness, grant-making to the Lupus Foundation of America’s Georgia Chapter and others. It will also include fundraising to support TRFL.

 

 

Mr. Reid also spoke about his success as a major behind-the-scenes figure in bringing about Atlanta’s status as a major cultural epicenter. He touched on ways he approached his major A&R responsibilities at LaFace Records. Highlights of this work included oversight of recording and/or remixes for the entire LaFace roster, including Toni Braxton, OutKast and TLC as well as his discovery of Usher Raymond.

 

He recounted memories of the night he found Usher at a talent show at Center Stage in Atlanta; how the LaFace A&R employee that he hired found the singer Pink; and the deal he secured which resulted in Donell Jones being signed at LaFace. Other highlights mentioned include his discovery of a young Jermaine Dupri, whom he hired to remix songs for Damian Dame; and TLC before his success with Kriss Kross. Mr. Reid concluded his remarks by discussing the reality-based music show he created in Atlanta on the Turner South Network back in 2002, a first of its kind.

 

The second speaker, Damon Stoudamire is currently the Head Coach for the Georgia Tech Yellow Jackets Men’s basketball program. He was the seventh overall pick by the Toronto Raptors in the 1995 NBA draft and won the NBA Rookie of the Year. Coach Stoudamire played collegiately at the University of Arizona and professionally for the Toronto Raptors, Portland Trail Blazers, Memphis Grizzlies, and San Antonio Spurs.

 

The meeting concluded with a reminder to the General Body of the mission of The 100 Black Men of Atlanta, which is to improve the quality of life by supporting and enhancing educational and economic opportunities, particularly for African-American youth in the Atlanta community.

 

READ MORE

Bryant Reid Tours The Lowance Center For Human Immunology At Emory

August 31, 2023

Bryant Reid, The Reid Foundation For Lupus Chair, met with Dr. Ignacio Sanz, Emory Division of Rheumatology Director, and Dr. Frances Lee, Emory Department of Medicine Associate Professor at The Lowance Center for Human Immunology.

The purpose of the Lowance Center for Human Immunology is to understand the immunological and molecular mechanisms responsible for human autoimmune, inflammatory, and allergic diseases. The Lowance Center studies both the innate and adaptive arms of the immune response and the mutual regulation of the two components.

According to the Mayo Clinic, lupus is a disease that occurs when your body’s immune system attacks your own tissues and organs (autoimmune disease). Inflammation caused by lupus can affect many different body systems — including your joints, skin, kidneys, blood cells, brain, heart, and lungs. It most often affects people of color, African American, Hispanic, and Asian people.

The importance of the Lowance Center’s research in advancing the understanding of lupus is obvious. The purpose of Mr. Reid’s tour was to provide him with a more in-depth understanding of the scope of work at the Lowance Center and to discuss possible ways The Reid Foundation for Lupus could support or enhance their work.

Dr. Sanz and Dr. Lee provided Mr. Reid with fundamental insights into the depth and scope of lupus research at the Lowance Center. The high ethical standards and transparency of the research at the Center were apparent throughout the tour.
Mentioned was the outstanding work performed by the faculty and in particular Dr. Sam Lim, The Reid Foundation For Lupus Board Member, Drs; Khosroshahi and Williams. Despite its excellent reputation, the Lowrance Center still struggles to find participants to assist them in the research required to understand — or cure –the disease.

The Reid Foundation for Lupus could be an invaluable partner in assisting the Lowance Center in encouraging communities of color to participate in their lupus research studies.

Mr. Reid felt the tour was an important step in building a working relationship between The Reid Foundation for Lupus and other institutions at the forefront of finding effective treatments and, ultimately, a cure for lupus.

READ MORE
Nation

Roberto Duran Supports The Reid Foundation For Lupus

August 31, 2023

Congratulations to Roberto Duran on his storied hall-of-fame career. He held the world championships in lightweight, welterweight, light middleweight, and middleweight classes.
Ring magazine voted him as the fifth greatest fighter of the last 80 years. He was also voted the best lightweight of the 20th century by the Associated Press.

The Reid Foundation for Lupus truly appreciates the support and is confident that with hard work and support from people like yourself, we can make a big difference.

READ MORE

© 2026 The Reid Foundation for Lupus – All Rights Reserved

The Reid Foundation for Lupus is a 501(c)(3) not-for-profit organization. 

Menu